New Enterprise Associates 13 Lp

Clovis Oncology, Inc.

10% Owner

Avg. Two Year Performance

320% Avg. Purchase Return    105% Compound
No Sale Track Record

Holdings: 2.28M shares

Last Three Months: 04-Feb-24 -- 03-May-24

0 Net Amount
Buy:0--
Sell:0--

Sentiment

Insider Trading Sentiment: Hold

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment:
Insider Trading Sentiment:
Insider Trading Sentiment:

Two Year Chart

04-May-22 -- 03-May-24

Price ($)

Sentiment

Company Sentiment

Most Recent Insider Transactions